Bayer Stock
Bayer Stock

Investor Information

Performance of Bayer Stock over the Past Twelve Months
Bayer stock performed very well in the third quarter of 2009 in a positive market environment. It gained 23.9% on the quarter, outperforming both the DAX (+18.0%) and the European reference index Euro Stoxx 50 (+19.9%).
At its closing price of €47.35 on September 30, 2009, the stock was up 14.0% from the end of 2008. Including the dividend of €1.40 per share paid on May 13, 2009, it posted a performance of 18.3%. The DAX gained 18.0% in the same period, closing at 5,675 points. The Euro Stoxx 50 improved by 21.1% since the beginning of the year, closing the third quarter at 4,529 points.

Bayer Stock Key Data
3rd Quarter 20083rd Quarter 2009First Nine Months 2008First Nine Months 2009
High for the period57.5348.8465.6848.84
Low for the period51.8035.6645.9032.69
Average daily share turnover on
German stock exchanges

million

4.9

3.8

5.5

4.5
  

Sept. 30, 2008


Sept. 30, 2009


Dec. 31,
2008
Change
Sept. 30, 2009/
Dec. 31, 2008
%
Share price51.8047.3541.55+14.0
Market capitalization€ million39,59339,15631,758+23.3
Equity as per statements of financial position€ million18,31018,25216,340+11.7
Number of shares entitled to the dividendmillion764.34826.95764.34+8.2
      
DAX 5,8315,6754,810+18.0

Xetra closing prices (source: Bloomberg)

Calculation of core earnings per share  

Earnings per share according to IFRS are affected by the purchase price allocation for acquisitions and other special factors. To enhance comparability, we also determine core net income from continuing operations after elimination of the amortization of intangible assets, asset write-downs (including any impairment losses), and special items in EBITDA including the related tax effects.
The calculation of earnings per share in accordance with IFRS is explained in the Notes to the Condensed Consolidated Interim Financial Statements. Adjusted core net income, core earnings per share and core EBIT are not defined in the IFRS. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
Calculation of Core EBIT and Core Earnings per Share3rd Quarter
2008
3rd Quarter
2009
First Nine Months 2008First Nine Months 2009
 € million€ million€ million€ million
EBIT as per income statements6846463,1322,640
Amortization and write-downs of intangible assets3853661,1701,112
Write-downs of property, plant and equipment3186360
Special items (other than write-downs)159173411263
Core EBIT1,2311,2034,7764,075
Non-operating result (as per income statements)(276)(262)(813)(888)
Income taxes (as per income statements)(133)(135)(701)(549)
Tax adjustment(151)(166)(484)(428)
Income after taxes attributable to non-controlling interest
(as per income statements)

(1)

0

(8)

3
Core net income from continuing operations6706402,7702,213
Financing expenses for the mandatory convertible bond, net of tax effects2808447
Adjusted core net income6986402,8542,260


Shares

Shares

Shares

Shares
Weighted average number of issued ordinary shares764,341,920826,947,808764,341,920792,321,971
(Potential) shares (to be) issued upon conversion of the mandatory convertible bond
60,040,823

0

59,843,529

33,366,875
Adjusted weighted average total number of issued and potential ordinary shares
824,382,743

826,947,808

824,185,449

825,688,846





Core earnings per share from continuing operations 0.850.783.462.74
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Print page
Search
Search
Advanced Search
Download Center
 
Links
Annual Report 2008
 
Sustainable Development Report 2008
 
Financial Reports
 
Comparison
Services
Order print version
 
Event Reminder
 
Press Newsletter
 
Would you like to be kept informed about new financial reports from Bayer?
 
SMS Service
 
Notes on our information package and all services
Calendar
Tuesday, October 27, 2009
Investor Conference Call
News Conference Call